← Eichor
Study identifier: NCT06053554 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome

Condition: Age Related Cataracts · Pseudoexfoliation Syndrome  ·  Sponsor: Medical University of Vienna

PhaseNA
Planned participants120
Who can joinAll sexes, 60 Years to 100 Years
Healthy volunteersNo

About this study

The aim of this study is to compare the surgical outcomes of the two IOL implantation methods for eyes with cataract and PEX in a single-center and with highly experienced surgeons. The goal is to acquire relevant information regarding these two IOL implantation techniques, which will help surgeons to decide which approach to choose, ultimately resulting in a benefit for patients with PEX syndrome who require cataract surgery. The main questions are: Is there a difference in lens tilt and decentration between the both methods. Is there a difference in the frequency and amount of capsular phimosis between the both methods.

This description comes directly from the study's public registry record.

Talk to the study team

Claudette ABELA-FORMANEK, Prof.Dr.  ·  +43(0)14040079680  ·  claudette.abela-formanek@meduniwien.ac.at

Markus Schranz, Dr.  ·  +43(0)14040079690  ·  markus.schranz@meduniwien.ac.at

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University of ViennaVienna, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06053554